{"id":22568,"date":"2011-12-02T07:33:13","date_gmt":"2011-12-02T12:33:13","guid":{"rendered":"http:\/\/asweetlife.org\/?p=22568"},"modified":"2015-12-30T04:26:58","modified_gmt":"2015-12-30T09:26:58","slug":"why-type-2-diabetes-patients-resist-intensifying-insulin-treatment-lilly-to-conduct-study","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=22568","title":{"rendered":"Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study"},"content":{"rendered":"<div style=\"text-align: justify;\"><a href=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg\" rel=\"mfp\"><img decoding=\"async\" class=\"alignleft size-full wp-image-22570 lazyload\" title=\"LillyDiabetes\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg\" alt=\"\" width=\"140\" height=\"160\" \/><\/a>Eli Lilly has announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles (MOSA1c study)\u00a0that people with type 2 diabetes face which prevent them from reaching their ultimate treatment goals.\u00a0<\/div>\n<div style=\"text-align: justify;\">\n<div>\u00a0<\/div>\n<\/div>\n<div style=\"text-align: justify;\">Despite daily treatment with insulin, many people with type 2 diabetes resist a progression of insulin therapy that could help them reach their ideal blood sugar target.\u00a0 As diabetes progresses, people often need to intensify their treatment by increasing their insulin to avoid spikes in blood sugar level. Though there is a great deal of research on why people with diabetes resist moving from oral medications to insulin, there is scarce information to help understand the barriers to insulin intensification. The aims of the MOSA1c study are to:<\/div>\n<div style=\"text-align: justify;\">\u00a0<\/div>\n<div>\n<div style=\"text-align: justify;\">\n<div>\n<div>Shed light on the non-clinical challenges and barriers associated with progressing insulin therapy\u00a0<\/div>\n<div>Help people with type 2 diabetes better understand and engage in their own diabetes management; and\u00a0<\/div>\n<div>Identify strategies to improve communication between patients and physicians, facilitating a tailored, personal approach to diabetes care that leads to improved glycemic control.<\/div>\n<\/div>\n<\/div>\n<div style=\"text-align: justify;\">\n<div>\u00a0<\/div>\n<div>Lilly has partnered with Brigham and Women&#8217;s Hospital and Harvard Medical School to conduct the study, which began enrolling patients in July 2011, following 4,500 people with type 2 diabetes taking insulin in the U.S. and 16 other countries for two years.\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>Lilly expects interim results from the MOSA1c study to be available in mid-2012.<\/div>\n<\/div>\n<div style=\"text-align: justify;\">\n<div>\u00a0<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly has announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles (MOSA1c study) that people with type 2 diabetes face which prevent them from reaching their ultimate treatment goals&#8230;<\/p>\n","protected":false},"author":131,"featured_media":22570,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1441],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study<\/title>\n<meta name=\"description\" content=\"Eli Lilly is conducting the first major study designed to understand the obstacles people with type 2 diabetes face when treated with insulin..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=22568\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=22568\",\"url\":\"https:\/\/asweetlife.org\/?p=22568\",\"name\":\"Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=22568#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=22568#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg\",\"datePublished\":\"2011-12-02T12:33:13+00:00\",\"dateModified\":\"2015-12-30T09:26:58+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"Eli Lilly is conducting the first major study designed to understand the obstacles people with type 2 diabetes face when treated with insulin..\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=22568#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=22568\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=22568#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg\",\"width\":200,\"height\":228},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=22568#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study","description":"Eli Lilly is conducting the first major study designed to understand the obstacles people with type 2 diabetes face when treated with insulin..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=22568","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=22568","url":"https:\/\/asweetlife.org\/?p=22568","name":"Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=22568#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=22568#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg","datePublished":"2011-12-02T12:33:13+00:00","dateModified":"2015-12-30T09:26:58+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"Eli Lilly is conducting the first major study designed to understand the obstacles people with type 2 diabetes face when treated with insulin..","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=22568#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=22568"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=22568#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2011\/12\/LillyDiabetes.jpg","width":200,"height":228},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=22568#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Why Type 2 Diabetes Patients Resist Intensifying Insulin Treatment, Lilly to Conduct Study"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/22568"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22568"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/22568\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/22570"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}